Skip to Main Content

Paper Details

Adding metabolic agents to prostate cancer therapy: Every rose has its thorn.
Eur J Cancer
0
2022
Author NameAffiliation
Ronald de WitErasmus Medical Center Cancer Institute
  • 1 - 1

Datasets

Release 1.2